Literature DB >> 12053086

Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients.

Cumhur Arici1, Okan Erdogan, Hasan Altunbas, Adil Boz, Mustafa Melikoglu, Binnur Karayalcin, Tuncer Karpuzoglu.   

Abstract

BACKGROUND: Thyroid carcinoma in childhood and adolescence is uncommon and because of the slow progression of disease the standard treatment is controversial. The aim of this study was to perform a retrospective analysis of treatment results for differentiated thyroid carcinoma in this age group treated in our clinic.
MATERIALS AND METHODS: From August 1988 to February 2001, 15 patients between the ages of 8 and 21 years (average 16.8) were treated for differentiated thyroid carcinoma at Akdeniz University Medical School Departments of General and Pediatric Surgery. The patients included 10 (67%) females and 5 (33%) males. None of the patients had a previous positive history of head and neck irradiation. All patients, except 2, were euthyroid at the time of diagnosis.
RESULTS: Nine of the patients underwent total thyroidectomy and in 6 cases subtotal thyroidectomy was performed. There were multiple lymph node metastases in 4 (27%) patients and (various forms of) cervical lymph node dissections were performed in these patients. In addition, 2 children (13%) showed pulmonary metastasis. The incidence of surgical complications was 20% (1 permanent, 1 transient hypoparathyroidism and 1 permanent laryngeal nerve injury). Histological examinations revealed the following: papillary carcinoma in 9 (60%), follicular carcinoma in 5 (33%) patients, and Hurthle cell carcinoma in 1 (7%) patient. Postoperative radioiodine ablation was also added to treatment in 10 (67%) of the patients and all patients received L-thyroxine in suppressive doses. After a median follow-up period of 57 months (range 5-149), all patients are alive and disease-free. CONCLUSUION: Our observations suggest that although most children and adolescents with differentiated thyroid carcinoma are seen with more extensive disease than adults, a total or subtotal thyroidectomy with an appropriate lymph node dissection followed by ablative radioiodine treatment carries a more favorable prognosis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053086     DOI: 10.1159/000058375

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

1.  Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.

Authors:  Francoise Borson-Chazot; Sylvain Causeret; Jean-Christophe Lifante; Marylin Augros; Nicole Berger; Jean-Louis Peix
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

Review 2.  Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.

Authors:  Geoffrey B Thompson; Ian D Hay
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

Review 3.  Evaluation and management of the pediatric thyroid nodule.

Authors:  Jeremy T Guille; Adwoa Opoku-Boateng; Susan L Thibeault; Herbert Chen
Journal:  Oncologist       Date:  2014-12-05

4.  Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.

Authors:  Ian D Hay; Tomas Gonzalez-Losada; Megan S Reinalda; Jennifer A Honetschlager; Melanie L Richards; Geoffrey B Thompson
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

5.  Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

Authors:  Yuri E Demidchik; Eugene P Demidchik; Christoph Reiners; Johannes Biko; Mariko Mine; Vladimir A Saenko; Shunichi Yamashita
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

6.  Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients.

Authors:  Bilge Volkan-Salancı; Pınar Özgen Kıratlı
Journal:  Mol Imaging Radionucl Ther       Date:  2015-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.